This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Viskin, S. Search for Related Content PubMed PubMed Citation Articles by Viskin, S. Related Collections Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2007;115:1970-1972.)
© 2007 American Heart Association, Inc.

Editorial

Brugada Syndrome in Children

Don’t Ask, Don’t Tell?

Sami Viskin, MD

From the Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Reprint requests to Sami Viskin, MD, Department of Cardiology, Tel Aviv Sourasky Medical Center, Weizman 6, Tel Aviv 64239, Israel. E-mail saviskin@tasmc.health.gov.il

Key Words: Editorials • antiarrhythmia agents • Brugada syndrome • death, sudden • electrical stimulation • genetics • tachyarrhythmias

An extract of the first 250 words of the full text is provided, because this article has no abstract.

In recent years, numerous asymptomatic individuals worldwide have undergone electrophysiological studies "only" because they have a pathological ECG indicative of Brugada syndrome.¹ Furthermore, at least 1 of 3 of these individuals had inducible ventricular fibrillation (VF) and underwent implantation of a cardioverter defibrillator (ICD).² "Asymptomatic Brugada syndrome with inducible VF" became an accepted indication for ICD implantation because data from a single large study showed that 12% of such patients develop spontaneous VF within 3 years of diagnosis.³ More recent (albeit smaller) studies, however, suggested that the risk for spontaneous VF in asymptomatic patients is lower.⁴ In fact, the most recent studies show that only 3%⁵ to 4%⁶ of individuals undergoing ICD implantation for "asymptomatic Brugada syndrome with inducible VF" developed spontaneous VF within 3 years of implantation. At the same time, as many as 28% of them developed ICD-related complications.⁶ The realization that we have done more harm than good to many asymptomatic individuals has reopened the debate on the optimal management of asymptomatic Brugada syndrome. Indeed, defining the role of electrophysiological testing in asymptomatic Brugada syndrome is probably the most heated debate in arrhythmology nowadays.^7,8 Fortunately, children have been spared from this debate because Brugada syndrome has been reported only rarely in minors, at least until now.

Article p 2042

In this issue of Circulation, Probst et al⁹ describe 30 children and adolescents (16 years of age) with Brugada syndrome. Their mean age was 8±5 years; 22 of them were <12 years of age. The circumstances . . . [Full Text of this Article]